Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Quizartinib Indicated for the Treatment of FLT3-ITD AML

Acute myeloid leukaemia is characterised by rapid build-up of abnormal cells in the bone marrow and blood. Image courtesy of VashiDonsk.



  • Quizartinib
  • Quizartinib
  • Quizartinib

Go Top